Business
DexCom's Strong Q4 Preliminary Results and Ambitious 2026 Outlook Fuel Investor Optimism
DexCom Inc. (DXCM) has released preliminary Q4 figures that exceeded expectations and provided robust long-term guidance, reinforcing its position as a favored pick among analysts and hedge funds in the medical devices sector.